CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 115 enrolled
Drug / intervention
Crosslinked hyaluronic acid gel (Juvéderm VOLUMA®)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01559064
NCT01559064N/ACompleted
CompareCT.gov

A Prospective, Observational Study of the Volumizing Effect of Open-Label Aesthetic Use of VOLUMA® in the Mid-Face Area

Allergan Medical·observational·Posted Mar 21, 2012·Updated Oct 13, 2014

In Brief

An observational study evaluating Crosslinked hyaluronic acid gel (Juvéderm VOLUMA®) for Age-related Volume Deficit in the Mid-face. Completed, enrolled 115 participants across 4 sites in 4 countries.

Detailed Summary

This is a prospective, observational study of the volumizing effect of aesthetic use of Juvéderm VOLUMA® with lidocaine in the mid-face area.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAge-related Volume Deficit in the Mid-face
CountriesBelgium, Germany, Netherlands, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 21, 2012
Enrollment StartFeb 1, 2012
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 14.3 years ago

Interventions

Crosslinked hyaluronic acid gel (Juvéderm VOLUMA®)device

All treatment details are at the discretion of the investigator and should be guided by the appropriate directions for use.